|
发表于 7-4-2018 12:57 AM
|
显示全部楼层
Date of change | 06 Apr 2018 | Name | MR TAN SIK EEK | Age | 41 | Gender | Male | Nationality | Malaysia | Designation | Executive Director | Directorate | Executive | Type of change | Appointment | Qualifications | Bachelor, Economics & Political Science in University of Sydney, Australia | Working experience and occupation | Tan Sik Eek has more than a decade of experience ranging from corporate finance advisory to private equity investments. He was previously a partner at House of Qin Ltd., a Beijing based private equity firm focused on investing in companies seeking growth funding and pre-IPO capital. Prior to that, Tan Sik Eek was the South East Asia Partner of Value Creation Strategies Sdn. Bhd., a Kuala Lumpur based advisory firm specialising in securing funding from a series of established North America global hedge funds, for companies listed on the regional capital markets. Tan Sik Eek held positions in companies like Devonshire Capital LLC, a boutique investment bank headquartered in Hong Kong as well as in the corporate finance division of RHB Investment Bank. | Directorships in public companies and listed issuers (if any) | 1. Fintech Global Bhd.2. NetX Holdings Bhd.3. AT Systematization Bhd.4. XOX Bhd. |
|
|
|
|
|
|
|
|
发表于 11-6-2018 01:54 AM
|
显示全部楼层
SUMMARY OF KEY FINANCIAL INFORMATION
31 Mar 2018 |
| INDIVIDUAL PERIOD | CUMULATIVE PERIOD | CURRENT YEAR QUARTER | PRECEDING YEAR
CORRESPONDING
QUARTER | CURRENT YEAR TO DATE | PRECEDING YEAR
CORRESPONDING
PERIOD | 31 Mar 2018 | 31 Mar 2017 | 31 Mar 2018 | 31 Mar 2017 | $$'000 | $$'000 | $$'000 | $$'000 |
1 | Revenue | 205 | 1,305 | 2,104 | 2,512 | 2 | Profit/(loss) before tax | -2,151 | -187 | -4,030 | -369 | 3 | Profit/(loss) for the period | -2,151 | -187 | -4,030 | -369 | 4 | Profit/(loss) attributable to ordinary equity holders of the parent | -1,999 | -191 | -3,884 | -205 | 5 | Basic earnings/(loss) per share (Subunit) | -0.30 | -0.10 | -0.58 | -0.11 | 6 | Proposed/Declared dividend per share (Subunit) | 0.00 | 0.00 | 0.00 | 0.00 |
|
| AS AT END OF CURRENT QUARTER | AS AT PRECEDING FINANCIAL YEAR END | 7
| Net assets per share attributable to ordinary equity holders of the parent ($$) | 0.0215 | 0.0513
|
|
|
|
|
|
|
|
|
发表于 28-8-2018 04:30 AM
|
显示全部楼层
本帖最后由 icy97 于 6-11-2018 01:56 AM 编辑
SUMMARY OF KEY FINANCIAL INFORMATION
30 Jun 2018 |
| INDIVIDUAL PERIOD | CUMULATIVE PERIOD | CURRENT YEAR QUARTER | PRECEDING YEAR
CORRESPONDING
QUARTER | CURRENT YEAR TO DATE | PRECEDING YEAR
CORRESPONDING
PERIOD | 30 Jun 2018 | 30 Jun 2017 | 30 Jun 2018 | 30 Jun 2017 | $$'000 | $$'000 | $$'000 | $$'000 |
1 | Revenue | 379 | 1,066 | 379 | 1,066 | 2 | Profit/(loss) before tax | -411 | 341 | -411 | 341 | 3 | Profit/(loss) for the period | -411 | 341 | -411 | 341 | 4 | Profit/(loss) attributable to ordinary equity holders of the parent | -376 | 290 | -376 | 290 | 5 | Basic earnings/(loss) per share (Subunit) | -0.06 | 0.16 | -0.06 | 0.16 | 6 | Proposed/Declared dividend per share (Subunit) | 0.00 | 0.00 | 0.00 | 0.00 |
|
| AS AT END OF CURRENT QUARTER | AS AT PRECEDING FINANCIAL YEAR END | 7
| Net assets per share attributable to ordinary equity holders of the parent ($$) | 0.2141 | 0.2154
|
|
|
|
|
|
|
|
|
发表于 25-9-2018 05:24 AM
|
显示全部楼层
Type | Announcement | Subject | TRANSACTIONS (CHAPTER 10 OF LISTING REQUIREMENTS)
NON RELATED PARTY TRANSACTIONS | Description | Acquisition of Property by Next Gen Biosciences Sdn. Bhd., a wholly-owned subsidiary of the Company | The Board of Directors of MLabs Systems Berhad ("Company") wishes to announce that Next Gen BioSciences Sdn. Bhd., a wholly-owed subsidiary of the Company has entered into a Sale and Purchase Agreement with Venus Assets Sdn. Bhd. and the details of the agreement is set out in the attachment. | http://www.bursamalaysia.com/market/listed-companies/company-announcements/5921217
|
|
|
|
|
|
|
|
发表于 27-9-2018 07:11 AM
|
显示全部楼层
Type | Reply to Query | Reply to Bursa Malaysia's Query Letter - Reference ID | IQL-25092018-00001 | Subject | Acquisition of Property by Next Gen Biosciences Sdn. Bhd., a wholly-owned subsidiary of MLABS Systems Berhad for a total purchase consideration of RM7,000,000 (Acquisition) | Description | Reply to the query from Bursa Malaysia Securities Berhad's letter dated 26 September 2018 (Reference No. IQL-25092018-00001) | Query Letter Contents | We refer to your Company’s announcement dated 24 September 2018 in respect of the aforesaid matter. In this connection, kindly furnish Bursa Securities with the following additional information for public release:- 1. The name of the development. 2. The percentage of completion or expected commencement date of the development. 3. The expected completion date of the development. 4. The terms of the tenure of the Property; if leasehold, the expiry date of the lease. 5. The basis of arriving at the purchase consideration other than on a “willing buyer and willing seller” basis and the justification for the purchase consideration. | Please refer to the attached document for the full reply. | http://www.bursamalaysia.com/market/listed-companies/company-announcements/5923989
|
|
|
|
|
|
|
|
发表于 27-12-2018 05:58 AM
|
显示全部楼层
SUMMARY OF KEY FINANCIAL INFORMATION
30 Sep 2018 |
| INDIVIDUAL PERIOD | CUMULATIVE PERIOD | CURRENT YEAR QUARTER | PRECEDING YEAR
CORRESPONDING
QUARTER | CURRENT YEAR TO DATE | PRECEDING YEAR
CORRESPONDING
PERIOD | 30 Sep 2018 | 30 Sep 2017 | 30 Sep 2018 | 30 Sep 2017 | $$'000 | $$'000 | $$'000 | $$'000 |
1 | Revenue | 3,476 | 248 | 3,855 | 1,313 | 2 | Profit/(loss) before tax | -2,270 | -1,920 | -2,681 | -1,578 | 3 | Profit/(loss) for the period | -2,270 | -1,920 | -2,681 | -1,578 | 4 | Profit/(loss) attributable to ordinary equity holders of the parent | -2,239 | -1,884 | -2,615 | -1,595 | 5 | Basic earnings/(loss) per share (Subunit) | -0.33 | -0.33 | -0.39 | -0.28 | 6 | Proposed/Declared dividend per share (Subunit) | 0.00 | 0.00 | 0.00 | 0.00 |
|
| AS AT END OF CURRENT QUARTER | AS AT PRECEDING FINANCIAL YEAR END | 7
| Net assets per share attributable to ordinary equity holders of the parent ($$) | 0.2150 | 0.2150
|
|
|
|
|
|
|
|
|
发表于 6-3-2019 04:25 AM
|
显示全部楼层
SUMMARY OF KEY FINANCIAL INFORMATION
31 Dec 2018 |
| INDIVIDUAL PERIOD | CUMULATIVE PERIOD | CURRENT YEAR QUARTER | PRECEDING YEAR
CORRESPONDING
QUARTER | CURRENT YEAR TO DATE | PRECEDING YEAR
CORRESPONDING
PERIOD | 31 Dec 2018 | 31 Dec 2017 | 31 Dec 2018 | 31 Dec 2017 | $$'000 | $$'000 | $$'000 | $$'000 |
1 | Revenue | 572 | 585 | 4,427 | 1,899 | 2 | Profit/(loss) before tax | -506 | -282 | -3,187 | -1,879 | 3 | Profit/(loss) for the period | -506 | -282 | -3,187 | -1,879 | 4 | Profit/(loss) attributable to ordinary equity holders of the parent | -486 | -269 | -3,101 | -1,885 | 5 | Basic earnings/(loss) per share (Subunit) | -0.07 | -0.11 | -0.46 | -0.74 | 6 | Proposed/Declared dividend per share (Subunit) | 0.00 | 0.00 | 0.00 | 0.00 |
|
| AS AT END OF CURRENT QUARTER | AS AT PRECEDING FINANCIAL YEAR END | 7
| Net assets per share attributable to ordinary equity holders of the parent ($$) | 0.2050 | 0.2150
|
|
|
|
|
|
|
|
|
发表于 5-7-2019 07:09 AM
|
显示全部楼层
Change in Financial Year End
Old financial year end | 31 Mar 2020 | New financial year end | 30 Jun 2019 |
Remarks : | The Board of Directors has approved the change of financial year end of the Company from 31 March to 30 June. The next audited financial statements of the Company shall be for a period of fifteen (15) months from 1 April 2018 to 30 June 2019 and thereafter, the financial year end shall be 30 June for each subsequent year.The purpose for the change of financial year end is for the Company to capture the impact of the launch of the Let's Talk App in June 2019. |
|
|
|
|
|
|
|
|
发表于 8-7-2019 07:33 AM
|
显示全部楼层
SUMMARY OF KEY FINANCIAL INFORMATION
31 Mar 2019 |
| INDIVIDUAL PERIOD | CUMULATIVE PERIOD | CURRENT YEAR QUARTER | PRECEDING YEAR
CORRESPONDING
QUARTER | CURRENT YEAR TO DATE | PRECEDING YEAR
CORRESPONDING
PERIOD | Three Months | Three Months | Twelve Months | Twelve Months | 01 Jan 2019
To | 01 Jan 2018
To | 01 Apr 2018
To | 01 Apr 2017
To | 31 Mar 2019 | 31 Mar 2018 | 31 Mar 2019 | 31 Mar 2018 | $$'000 | $$'000 | $$'000 | $$'000 |
1 | Revenue | 201 | 205 | 4,628 | 2,104 | 2 | Profit/(loss) before tax | -2,323 | -2,160 | -5,510 | -4,040 | 3 | Profit/(loss) for the period | -2,323 | -2,160 | -5,510 | -4,040 | 4 | Profit/(loss) attributable to ordinary equity holders of the parent | -2,240 | -2,008 | -5,341 | -3,894 | 5 | Basic earnings/(loss) per share (Subunit) | -0.33 | -0.49 | -0.80 | -0.94 | 6 | Proposed/Declared dividend per share (Subunit) | 0.00 | 0.00 | 0.00 | 0.00 |
|
| AS AT END OF CURRENT QUARTER | AS AT PRECEDING FINANCIAL YEAR END | 7
| Net assets per share attributable to ordinary equity holders of the parent ($$) | 0.1970 | 0.2150
|
|
|
|
|
|
|
|
|
发表于 8-7-2019 07:39 AM
|
显示全部楼层
|
|
|
|
|
|
|
发表于 1-9-2019 06:24 AM
|
显示全部楼层
SUMMARY OF KEY FINANCIAL INFORMATION
30 Jun 2019 |
| INDIVIDUAL PERIOD | CUMULATIVE PERIOD | CURRENT YEAR QUARTER | PRECEDING YEAR
CORRESPONDING
QUARTER | CURRENT YEAR TO DATE | PRECEDING YEAR
CORRESPONDING
PERIOD | Three Months | Three Months | Three Months | Three Months | 01 Apr 2019
To | 01 Apr 2018
To | 01 Apr 2019
To | 01 Apr 2018
To | 30 Jun 2019 | 30 Jun 2018 | 30 Jun 2019 | 30 Jun 2018 | $$'000 | $$'000 | $$'000 | $$'000 |
1 | Revenue | 3,158 | 379 | 7,786 |
| 2 | Profit/(loss) before tax | -294 | -410 | -5,804 |
| 3 | Profit/(loss) for the period | -294 | -410 | -5,804 |
| 4 | Profit/(loss) attributable to ordinary equity holders of the parent | -332 | -375 | -5,674 |
| 5 | Basic earnings/(loss) per share (Subunit) | -0.05 | -0.06 | -0.85 |
| 6 | Proposed/Declared dividend per share (Subunit) | 0.00 | 0.00 | 0.00 |
|
|
| AS AT END OF CURRENT QUARTER | AS AT PRECEDING FINANCIAL YEAR END | 7
| Net assets per share attributable to ordinary equity holders of the parent ($$) | 0.0940 | 0.0980
|
|
|
|
|
|
|
|
|
发表于 28-1-2020 07:45 AM
|
显示全部楼层
Particulars of substantial Securities HolderName | FIRST UNITED TECHNOLOGY LIMITED | Address | 6/F CNT, COMMERCIAL BUILDING
NO. 302, QUEEN'S ROAD CENTRAL
Hong Kong. | Company No. | 2356056 | Nationality/Country of incorporation | Hong Kong | Descriptions (Class) | Ordinary Shares | Details of changesNo | Date of change | No of securities | Type of Transaction | Nature of Interest | 1 | 15 Nov 2019 | 24,600,000 | Acquired | Direct Interest | Name of registered holder | First United Technology Limited | Address of registered holder | 6/F CNT Commercial Building No. 302, Queen's Road Central Hong Kong | Description of "Others" Type of Transaction | |
Circumstances by reason of which change has occurred | Acquisition of Shares in the Open Market | Nature of interest | Direct Interest | Direct (units) | 88,700,000 | Direct (%) | 13.229 | Indirect/deemed interest (units) |
| Indirect/deemed interest (%) |
| Total no of securities after change | 88,700,000 | Date of notice | 18 Nov 2019 | Date notice received by Listed Issuer | 18 Nov 2019 |
|
|
|
|
|
|
|
|
发表于 31-1-2020 03:48 AM
|
显示全部楼层
Particulars of substantial Securities HolderName | FIRST UNITED TECHNOLOGY LIMITED | Address | 6/F CNT, COMMERCIAL BUILDING
NO. 302, QUEEN'S ROAD CENTRAL
Hong Kong. | Company No. | 2356056 | Nationality/Country of incorporation | Hong Kong | Descriptions (Class) | Ordinary Shares | Details of changesNo | Date of change | No of securities | Type of Transaction | Nature of Interest | 1 | 18 Nov 2019 | 26,500,000 | Acquired | Direct Interest | Name of registered holder | First United Technology Limited | Address of registered holder | 6/F CNT Commercial Building No. 302, Queen's Road Central Hong Kong | Description of "Others" Type of Transaction | |
Circumstances by reason of which change has occurred | Acquisition of Shares in the Open Market | Nature of interest | Direct Interest | Direct (units) | 115,200,000 | Direct (%) | 17.181 | Indirect/deemed interest (units) |
| Indirect/deemed interest (%) |
| Total no of securities after change | 115,200,000 | Date of notice | 19 Nov 2019 | Date notice received by Listed Issuer | 19 Nov 2019 |
|
|
|
|
|
|
|
|
发表于 20-3-2020 06:21 AM
|
显示全部楼层
SUMMARY OF KEY FINANCIAL INFORMATION
30 Sep 2019 |
| INDIVIDUAL PERIOD | CUMULATIVE PERIOD | CURRENT YEAR QUARTER | PRECEDING YEAR
CORRESPONDING
QUARTER | CURRENT YEAR TO DATE | PRECEDING YEAR
CORRESPONDING
PERIOD | 30 Sep 2019 | 30 Sep 2018 | 30 Sep 2019 | 30 Sep 2018 | $$'000 | $$'000 | $$'000 | $$'000 |
1 | Revenue | 6,531 | 3,476 | 6,531 |
| 2 | Profit/(loss) before tax | -1,009 | -2,271 | -1,009 |
| 3 | Profit/(loss) for the period | -1,009 | -2,271 | -1,009 |
| 4 | Profit/(loss) attributable to ordinary equity holders of the parent | -721 | -2,240 | -721 |
| 5 | Basic earnings/(loss) per share (Subunit) | -0.11 | -0.33 | -0.11 |
| 6 | Proposed/Declared dividend per share (Subunit) | 0.00 | 0.00 | 0.00 |
|
|
| AS AT END OF CURRENT QUARTER | AS AT PRECEDING FINANCIAL YEAR END | 7
| Net assets per share attributable to ordinary equity holders of the parent ($$) | 0.0920 | 0.0940
|
|
|
|
|
|
|
|
|
发表于 5-4-2020 08:14 AM
|
显示全部楼层
Date of change | 31 Dec 2019 | Name | MAJ (R) MEJAR DATO' ISMAIL BIN AHMAD (R) | Age | 70 | Gender | Male | Nationality | Malaysia | Type of change | Redesignation | Previous Position | Executive Director | New Position | Non Executive Director | Directorate | Non Independent and Non Executive |
Date of change | 31 Dec 2019 | Name | MR ONG TEE KEIN | Age | 62 | Gender | Male | Nationality | Malaysia | Type of change | Redesignation | Previous Position | Executive Director | New Position | Non Executive Director | Directorate | Non Independent and Non Executive |
|
|
|
|
|
|
|
|
发表于 20-4-2020 06:57 AM
|
显示全部楼层
1. Details of Corporate Proposal | Involve issuance of new type/class of securities ? | No | Types of corporate proposal | ESOS | Details of corporate proposal | Employees' Share Option Scheme | No. of shares issued under this corporate proposal | 100,000,000 | Issue price per share ($$) | Malaysian Ringgit (MYR) 0.0300 | Par Value($$) (if applicable) |
| Latest issued share capital after the above corporate proposal in the following | Units | 770,584,027 | Issued Share Capital ($$) | Malaysian Ringgit (MYR) 33,633,181.000 | Listing Date | 13 Feb 2020 |
|
|
|
|
|
|
|
|
发表于 3-5-2020 07:59 AM
|
显示全部楼层
SUMMARY OF KEY FINANCIAL INFORMATION
31 Dec 2019 |
| INDIVIDUAL PERIOD | CUMULATIVE PERIOD | CURRENT YEAR QUARTER | PRECEDING YEAR
CORRESPONDING
QUARTER | CURRENT YEAR TO DATE | PRECEDING YEAR
CORRESPONDING
PERIOD | 31 Dec 2019 | 31 Dec 2018 | 31 Dec 2019 | 31 Dec 2018 | $$'000 | $$'000 | $$'000 | $$'000 |
1 | Revenue | 383 | 572 | 6,914 | 0 | 2 | Profit/(loss) before tax | -2,294 | -506 | -3,303 | 0 | 3 | Profit/(loss) for the period | -2,294 | -506 | -3,303 | 0 | 4 | Profit/(loss) attributable to ordinary equity holders of the parent | -2,231 | -486 | -2,979 | 0 | 5 | Basic earnings/(loss) per share (Subunit) | -0.33 | -0.07 | -0.45 | 0.00 | 6 | Proposed/Declared dividend per share (Subunit) | 0.00 | 0.00 | 0.00 | 0.00 |
|
| AS AT END OF CURRENT QUARTER | AS AT PRECEDING FINANCIAL YEAR END | 7
| Net assets per share attributable to ordinary equity holders of the parent ($$) | 0.0890 | 0.0940
|
|
|
|
|
|
|
|
|
发表于 17-5-2020 07:34 AM
|
显示全部楼层
Expiry/Maturity of the securities
Instrument Category | Securities of PLC | Instrument Type | Warrants | Type Of Expiry | Expiry/Maturity of the securities | Mode of Satisfaction of Exercise/Conversion price | Cash | Exercise/ Strike/ Conversion Price | Malaysian Ringgit (MYR) 0.0900 | Exercise/ Conversion Ratio | 1:1 | Settlement Type / Convertible into | Physical (Shares) | Last Date & Time of Trading | 09 Apr 2020 05:00 PM | Date & Time of Suspension | 10 Apr 2020 09:00 AM | Last Date & Time for Transfer into Depositor's CDS a/c | 20 Apr 2020 04:30 PM | Date & Time of Expiry | 27 Apr 2020 05:00 PM | Date & Time for Delisting | 28 Apr 2020 09:00 AM | https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3038530
|
|
|
|
|
|
|
|
发表于 19-5-2020 06:56 AM
|
显示全部楼层
本帖最后由 icy97 于 21-5-2020 05:30 AM 编辑
Type | Announcement | Subject | OTHERS | Description | MLABS SYSTEMS BERHAD - COLLABORATION AND CO-OPERATION AGREEMENT WITH IPHARMA (MALAYSIA) SDN. BHD. | The Board of Directors (“Board”) of Mlabs Systems Berhad (“Mlabs” or the “Company”) wishes to inform that Mlabs Research Sdn. Bhd. (formerly known as Multimedia Research Lab Sdn Bhd) (“Mlabs Research”), a wholly-owned subsidiary of the Company, had on 27 March 2020 entered into a Collaboration and Co-operation Agreement (“Agreement”) with Ipharmacare (Malaysia) Sdn. Bhd. (“Ipharmacare”) for the proposed collaboration whereby Mlabs Research shall provide its products including but not limited to video-conferencing systems, messaging systems and network solutions (“Products”) to Ipharmacare and Ipharmacare shall incorporate the Products to complement to its Online Pharmaceutical Platform known as iPharma.care as necessary and support Mlabs Research’s effort to promote the Products to its platform users and/or independent pharmacies.
Ipharmacare is a private limited company incorporated in Malaysia which primarily involved in the business of providing online pharmaceutical products and services to merchants and customers through its online pharmaceutical platform.
The Agreement is for a period of 3 years, commencing on and from 27 March 2020, unless otherwise mutually extended or terminated. Either party may terminate the Agreement upon delivery of written notice at least 90 days prior to such termination.
The Agreement will not have any effects on the share capital and shareholding structure of the Company. However, it is expected to have positive contribution to the earnings and net assets of Mlabs Group.
Similar to all business entities, the risk factors affecting the execution of the Agreement, including but not limited to business risks such as prudent financial management, changes in political, economic and regulatory conditions. However, the Board will continue to exercise due care in considering the risks associated with the Agreement and will take appropriate measures in planning the successful execution of the Agreement.
The Agreement being incurred in the ordinary course of business, is not subject to the approval of the shareholders.
None of the Directors and/or other major shareholders of the Company and/ or any persons connected to them have any interest, direct or indirect, in relation to the Agreement.
The Board, after due consideration, is of the opinion that the Agreement is in the best interest of the Group.
This announcement is dated 27 March 2020.
|
Type | Announcement | Subject | OTHERS | Description | MLABS SYSTEMS BERHAD - COLLABORATION AND CO-OPERATION AGREEMENT WITH IPHARMACARE (MALAYSIA) SDN. BHD. | Reference is made to the Company’s announcement made on 27 March 2020.
Mlabs Systems Berhad (“Mlabs” or the “Company”) wishes to further announce that the collaboration with Ipharmacare (Malaysia) Sdn. Bhd. is in line with the Company’s strategy to expand its solution into pharmaceutical industry throughout Malaysia, thereafter Southeast Asia for the next 3 years. The overall areas of collaboration will include technical know-how, marketing and distribution of platform content, as well as marketing and promotion in Malaysia. It will allow Mlabs to generate revenue through renewal of software licensing, maintenance services and programmatic advertising.
This announcement is dated 1 April 2020.
|
|
|
|
|
|
|
|
|
发表于 23-5-2020 07:03 AM
|
显示全部楼层
1. Details of Corporate Proposal | Involve issuance of new type/class of securities ? | No | Types of corporate proposal | ESOS | Details of corporate proposal | Employees' Share Option Scheme | No. of shares issued under this corporate proposal | 31,000,000 | Issue price per share ($$) | Malaysian Ringgit (MYR) 0.0150 | Par Value($$) (if applicable) |
| Latest issued share capital after the above corporate proposal in the following | Units | 801,584,027 | Issued Share Capital ($$) | Malaysian Ringgit (MYR) 34,098,181.000 | Listing Date | 08 Apr 2020 |
|
|
|
|
|
|
|
| |
本周最热论坛帖子
|